SCHEMBL5865162

SCHEMBL5865162

COc1ccc2c(c1)C=C(c1cc(N)ccn1)CC2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 7/20 0.54
CYP11B1 P15538 5/20 0.47
CYP19A1 P11511 3/20 0.43
CCR1 P32246 1/20 0.41
CCR5 P51681 1/20 0.41
CCR8 P51685 1/20 0.41
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPT P10636 2/20 0.40
HTT P42858 1/20 0.40
PTGS2 P35354 1/20 0.40
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
NOS2 P35228 1/20 0.39
PLAU P00749 1/20 0.37
MPI P34949 1/20 0.36
OPRD1 P41143 1/20 0.36
KCNH2 Q12809 1/20 0.36
ASIC3 Q9UHC3 1/20 0.35
DYRK1A Q13627 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL5865549 0.90 CYP11B2 (0.48) CYP11B2CYP11B1CYP19A1CCR1CCR5
Fumaric Acid SCHEMBL5865541 0.90 CYP11B2 (0.48) CYP11B2CYP11B1CYP19A1CCR1CCR5
SCHEMBL5865035 0.80 ASIC3 (0.37) CYP11B2KCNH2ASIC3DYRK1AHTR5A
SCHEMBL5865110 0.78 ASIC3 (0.47) CYP11B2CYP11B1CYP19A1KDM4EALDH1A1
Hydrochloric Acid SCHEMBL5865331 0.77 ASIC3 (0.46) CYP11B2CYP11B1CYP19A1KDM4EALDH1A1
SCHEMBL5865544 0.75 CYP11B2 (0.47) CYP11B2CYP11B1CYP19A1CCR1CCR5
SCHEMBL5864840 0.74 ASIC3 (0.38) CYP19A1KDM4EALDH1A1PTGS2OPRD1
SCHEMBL22568903 0.72 CYP11B2 (0.72) CYP11B2CYP11B1CYP19A1PTGS2
Fumaric Acid SCHEMBL27590119 0.72 HRH1 (0.36) ASIC3
Fumaric Acid SCHEMBL5865311 0.72 HRH1 (0.36) ASIC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7034044-B2 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. (US) 2006-04-25 US disclosed
US-20060058354-A1 Conjugated aromatic compounds with a pyridine substituent ALANINE ALEXANDER 2006-03-16 US disclosed
US-6951875-B2 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. (US) 2005-10-04 US disclosed
US-20040068118-A1 Conjugated aromatic compounds with a pyridine substituent ALANINE ALEXANDER (FR) 2004-04-08 US disclosed
US-20030144525-A1 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. 2003-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040068118-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN1, GRIN2C CYP11B2 317/4885CYP11B1 359/4885CYP19A1 1693/4885
US-20030144525-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN1, GRIN2C CYP11B2 317/4885CYP11B1 359/4885CYP19A1 1693/4885
US-20060058354-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN3A, GRIN2C CYP11B2 379/4885CYP11B1 445/4885CYP19A1 2025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.